Efficacy of half-dose verteporfin photodynamic therapy for central serous chorioretinophathy in patients aged above 45
AIM: To evaluate the efficacy of half-dose verteporfin photodynamic therapy for central serous chorioretinophathy(CSC)in patients aged above 45 years old. <p>METHODS: Thirty-two eyes of 30 patients aged above 45 years old with central serous chorioretinophathy were included, and all the eyes r...
Main Authors: | Yi-Jun Wu, Gen-Gui Xu, Li Mo, Jian-Feng Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2017-11-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2017/11/201711026.pdf |
Similar Items
-
Retrospective study on half-dose verteporfin photodynamic therapy for treatment of chronic central serous chorioretinopathy
by: Xin Sun, et al.
Published: (2015-10-01) -
Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
by: Dhirani NA, et al.
Published: (2017-12-01) -
Photodynamic therapy with one third-dose verteporfin for treating acute central serous chorioretinopathy
by: Bo Zheng, et al.
Published: (2013-08-01) -
Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
by: Pierluigi Iacono, et al.
Published: (2020-10-01) -
Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
by: Kyoko Fujita, et al.
Published: (2020-12-01)